Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib

I. Messaritakis,E. Politaki,M. Plataki, V. Karavassilis,N. Kentepozidis,F. Koinis,E. Samantas,V. Georgoulias,A. Kotsakis

Lung Cancer（2017）

引用 23|浏览13

暂无评分

摘要

•Pazopanib is a small molecule with a tyrosine multikinase inhibitor activity.•CTCs detection could serve as a prognostic and predictive tool in SCLC.•Pazopanib effect on CTCs was an early event, and even after one treatment cycle.

查看译文

关键词

TTF-1,CD56,VEGFR2,Immunofluorescence,CellSearch,SCLC,CTCs,Pazopanib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要